Modeling the Contribution of Male Testosterone Levels to the Duration of Positive COVID Testing among Hospitalized Male COVID-19 Patients
Authors:
- Stefano SalcicciaSSStefano Salciccia
- Michael L. EisenbergMEMichael L. Eisenberg
- Martina MaggiMartina Maggi
- Silvia LaiSLSilvia Lai
- Claudio Maria MastroianniCMClaudio Maria Mastroianni
- Patrizia PasculliPPPatrizia Pasculli
- Maria Rosa CiardiMCMaria Rosa Ciardi
- Vittorio CanaleVCVittorio Canale
- Matteo FerroMFMatteo Ferro
- Gian Maria BusettoGian Maria Busetto
- Ettore De BerardinisEBEttore De Berardinis
- Gian Piero RicciutiGRGian Piero Ricciuti
Open Access
- 24 March 2021
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 11 (4) , 581
Abstract
Background: A growing body of evidence is emerging suggesting testosterone can affect all cells involved in the immune response to both bacterial and viral infections, and the testosterone effect on the immune response could explain the greater susceptibility of men to infections including COVID-19. We aimed to explore the predictive role of male serum total testosterone (TT) levels on the time till viral negativity testing among hospitalized COVID-19 patients. Methods: The univariate effect of risk factors for the duration of COVID-19 viral positivity was evaluated using the log-rank test and Kaplan–Meier estimates. A multivariable Cox regression model was developed to test the role of TT levels and the subsequent odds for shorter viral positivity intervals. Results: Increasing serum TT levels and the need for an oxygen administration strategy were independently predictive for respectively reduced and increased days to negativization (Hazard Ratio [HR]: 1.39, 95% CI: 0.95–2.03 and HR: 0.19, 95% CI: 0.03–1.18). Conclusion: Baseline higher TT levels for male COVID-19 patients at hospital admission are associated with shorter durations of positive COVID-19 testing and thus viral clearance. Our preliminary findings might play a relevant to help pandemic control strategies if these will be verified in future larger multicentric and possibly randomized trials.Keywords
This publication has 39 references indexed in Scilit:
- Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in SingaporeJAMA, 2020
- Coronavirus Disease 2019 (COVID-19) in ItalyJAMA, 2020
- Virological assessment of hospitalized patients with COVID-2019Nature, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Virology, Epidemiology, Pathogenesis, and Control of COVID-19Viruses, 2020
- Urogenital infectionsWorld Journal of Urology, 2019
- Androgen-Induced ImmunosuppressionFrontiers in Immunology, 2018
- Testosterone Deficiency and Testosterone Treatment in Older MenGerontology, 2016
- The Androgen-Regulated Protease TMPRSS2 Activates a Proteolytic Cascade Involving Components of the Tumor Microenvironment and Promotes Prostate Cancer MetastasisCancer Discovery, 2014
- Low Testosterone Levels are Frequent in Patients with Acute Respiratory Failure and Are Associated with Poor OutcomesEndocrine Practice, 2014